Stefan 2020 Nat Rev Endocrinol
From Bioblast
Revision as of 13:40, 5 May 2020 by Gnaiger Erich (talk | contribs) (Created page with "{{Publication |title=Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS (2020) Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol 2020:1‐2 [publ...")
| Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS (2020) Obesity and impaired metabolic health in patients with COVID-19. Nat Rev Endocrinol 2020:1‐2 [published online ahead of print, 2020 Apr 23].. |
Stefan N, Birkenfeld AL, Schulze MB, Ludwig DS (2020) Nat Rev Endocrinol
Abstract: Preliminary data suggest that people with obesity are at increased risk of severe COVID-19. However, as data on metabolic parameters (such as BMI and levels of glucose and insulin) in patients with COVID-19 are scarce, increased reporting is needed to improve our understanding of COVID-19 and the care of affected patients.
• Bioblast editor: Gnaiger E
Labels: MiParea: Patients
Pathology: Cardiovascular, Diabetes, Infectious, Obesity
Organism: Human
Preparation: Intact organism
Comorbidity, BMI, mitObesity2020, Virus
